$5.69
-0.2-3.40%
Pre-Market: Sep 20, 7:56 PM EDT
15 minutes delayed
Aldeyra Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Aldeyra Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-01 | $-0.28 | $-0.15 | -86.7 % |
Mar 2024 | 2024-05-02 | $-0.14 | $-0.14 | 0.00 % |
Dec 2023 | 2024-03-07 | $-0.08 | $-0.14 | 42.9 % |
Sep 2023 | 2023-11-03 | $-0.14 | $-0.24 | 41.7 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Dec 2023 | 2024-03-07 | $0 | $1.86M | -100.0 % |
Aldeyra Therapeutics (ALDX) is scheduled to report earnings on November 1, 2024. The last reported earnings were for reported on August 1, 2024 for Q2.
The Actual EPS was $-0.28, which missed the estimate of $-0.15.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.